Super gonorrhea rate quickly triples in China, now 40X higher than US
Briefly

from Ars Technica9 months ago
In the US, for instance, the prevalence of ceftriaxone-resistant strains never went above 0.2 percent between 2017 and 2021.
Ars Technicahttps://arstechnica.com/science/2024/03/super-gonorrhea-rate-quickly-triples-in-china-now-40x-higher-than-us/
Read at Ars Technica
#gonorrhea #antibiotic-resistance #ceftriaxone #public-health #drug-resistance
[
|
]